The Latin America, Middle East and Africa Diabetes Care Devices Market would witness market growth of 7.6% CAGR during the forecast period (2022-2028).
An increase in the incidence of diabetes, as well as changes in urbanization and sedentary lifestyle, is driving the diabetes care devices market growth. Furthermore, technical improvements in the field of diabetes devices, an increase in the diabetic population around the world, an increase in the demand for fast and safe diagnoses, and a rise in diabetes therapies would drive the diabetes care market in the coming years.
A significant prevalence of the geriatric population, economical healthcare facilities, cost-effective labor, and relatively lax regulatory laws are all driving diabetic device manufacturers to expand their operations. To acquire maximum market share, manufacturers are now focusing on maximizing prospects in developing economies. The advent of high-end insulin pumps and pens, as well as technological developments in diabetic devices, are driving demand for these items. To capture a significant portion of the market, leading manufacturers are focused on technological advances and the creation of innovative products.
There is a significant number of people with obesity in this region. According to the National Library of Medicine, obesity rates among adolescents and children in Gulf countries range from 5% to 14% for men and 3% to 18% for females. Obesity is on the rise in the Gulf region, with prevalence rates ranging from 2% to 55% in adult females and 1% to 30% in adult males. Obesity in the UAE is twice as high as the global norm, In Kuwait, more than half of the adult population has diabetes connected to obesity, and 75% of Egyptians are overweight owing to the desert climate. Obesity rates have been rising in the Middle East and North Africa due to poor urban design, cultural issues (behavioral standards, both indoors and outdoors), unhealthy food habits, and other causes.
The Brazil market dominated the LAMEA Diabetes Care Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $495.4 Million by 2028. The Argentina market is experiencing a CAGR of 8.2% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 7.3% during (2022 - 2028).
Based on Product, the market is segmented into Insulin Delivery Devices and Blood Glucose Monitoring Devices. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Diabetes Care Devices Market is Predict to reach $29.3 Billion by 2028, at a CAGR of 6.6%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., DexCom, Inc., Novo Nordisk A/S, Sanofi S.A., Zealand Pharma A/S, B. Braun Melsungen AG, Bayer AG, Abbott Laboratories, Ypsomed AG, Arkray, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Insulin Delivery Devices and
- Blood Glucose Monitoring Devices
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- F. Hoffmann-La Roche Ltd.
- DexCom, Inc.
- Novo Nordisk A/S
- Sanofi S.A.
- Zealand Pharma A/S
- B. Braun Melsungen AG
- Bayer AG
- Abbott Laboratories
- Ypsomed AG
- Arkray, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Diabetes Care Devices Market, by Product
1.4.2 LAMEA Diabetes Care Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements : 2018, Oct – 2022, May) Leading Players
Chapter 4. LAMEA Diabetes Care Devices Market by Product
4.1 LAMEA Insulin Delivery Devices Market by Country
4.2 LAMEA Blood Glucose Monitoring Devices Market by Country
Chapter 5. LAMEA Diabetes Care Devices Market by Country
5.1 Brazil Diabetes Care Devices Market
5.1.1 Brazil Diabetes Care Devices Market by Product
5.2 Argentina Diabetes Care Devices Market
5.2.1 Argentina Diabetes Care Devices Market by Product
5.3 UAE Diabetes Care Devices Market
5.3.1 UAE Diabetes Care Devices Market by Product
5.4 Saudi Arabia Diabetes Care Devices Market
5.4.1 Saudi Arabia Diabetes Care Devices Market by Product
5.5 South Africa Diabetes Care Devices Market
5.5.1 South Africa Diabetes Care Devices Market by Product
5.6 Nigeria Diabetes Care Devices Market
5.6.1 Nigeria Diabetes Care Devices Market by Product
5.7 Rest of LAMEA Diabetes Care Devices Market
5.7.1 Rest of LAMEA Diabetes Care Devices Market by Product
Chapter 6. Company Profiles
6.1 F. Hoffmann-La Roche Ltd.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Partnerships, Collaborations, and Agreements:
6.1.5.2 Product Launches and Product Expansions:
6.2 DexCom, Inc.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Partnerships, Collaborations, and Agreements:
6.2.5.2 Product Launches and Product Expansions:
6.2.5.3 Acquisition and Mergers:
6.3 Novo Nordisk A/S
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental & Regional Analysis
6.3.4 Research & Development Expenses
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Acquisition and Mergers:
6.4 Sanofi S.A.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaborations, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Zealand Pharma A/S (Valeritas, Inc.)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Research & Development Expenses
6.5.4 Recent strategies and developments:
6.5.4.1 Product Launches and Product Expansions:
6.5.4.2 Approvals and Trials:
6.6 B. Braun Melsungen AG
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.6.5 Recent strategies and developments:
6.6.5.1 Partnerships, Collaborations, and Agreements:
6.7 Bayer AG
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Partnerships, Collaborations, and Agreements:
6.7.5.2 Approvals:
6.8 Abbott Laboratories
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.8.5 Recent strategies and developments:
6.8.5.1 Partnerships, Collaborations, and Agreements:
6.8.5.2 Approvals:
6.9 Ypsomed AG
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Segmental and Regional Analysis
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.10. Arkray, Inc.
6.10.1 Company Overview
6.10.2 Recent strategies and developments:
6.10.2.1 Partnerships, Collaborations, and Agreements:
6.10.2.2 Geographical Expansions:
TABLE 1 LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 2 LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Diabetes Care Devices Market
TABLE 4 Product Launches And Product Expansions– Diabetes Care Devices Market
TABLE 5 Acquisition and Mergers– Diabetes Care Devices Market
TABLE 6 Geographical expansion– Diabetes Care Devices Market
TABLE 7 Approvals and Trials– Diabetes Care Devices Market
TABLE 8 LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 9 LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 10 LAMEA Insulin Delivery Devices Market by Country, 2018 - 2021, USD Million
TABLE 11 LAMEA Insulin Delivery Devices Market by Country, 2022 - 2028, USD Million
TABLE 12 LAMEA Blood Glucose Monitoring Devices Market by Country, 2018 - 2021, USD Million
TABLE 13 LAMEA Blood Glucose Monitoring Devices Market by Country, 2022 - 2028, USD Million
TABLE 14 LAMEA Diabetes Care Devices Market by Country, 2018 - 2021, USD Million
TABLE 15 LAMEA Diabetes Care Devices Market by Country, 2022 - 2028, USD Million
TABLE 16 Brazil Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 17 Brazil Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 18 Brazil Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 19 Brazil Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 20 Argentina Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 21 Argentina Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 22 Argentina Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 23 Argentina Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 24 UAE Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 25 UAE Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 26 UAE Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 27 UAE Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 28 Saudi Arabia Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 29 Saudi Arabia Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 30 Saudi Arabia Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 31 Saudi Arabia Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 32 South Africa Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 33 South Africa Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 34 South Africa Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 35 South Africa Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 36 Nigeria Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 37 Nigeria Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 38 Nigeria Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 39 Nigeria Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 40 Rest of LAMEA Diabetes Care Devices Market, 2018 - 2021, USD Million
TABLE 41 Rest of LAMEA Diabetes Care Devices Market, 2022 - 2028, USD Million
TABLE 42 Rest of LAMEA Diabetes Care Devices Market by Product, 2018 - 2021, USD Million
TABLE 43 Rest of LAMEA Diabetes Care Devices Market by Product, 2022 - 2028, USD Million
TABLE 44 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 45 Key Information – DexCom, Inc.
TABLE 46 Key information – Novo Nordisk A/S
TABLE 47 Key Information – Sanofi S.A.
TABLE 48 Key Information – Zealand Pharma A/S
TABLE 49 key Information – B. Braun Melsungen AG
TABLE 50 Key Information – Bayer AG
TABLE 51 Key Information – Abbott Laboratories
TABLE 52 Key Information –-Ypsomed AG
TABLE 53 Key Information – Arkray, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Partnerships, collaborations and agreements : 2018, oct – 2022, may) Leading Players
FIG 5 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 6 Recent strategies and developments: DexCom, Inc.
FIG 7 Recent strategies and developments: Novo Nordisk A/S
FIG 8 Recent strategies and developments: Sanofi S.A.
FIG 9 Recent strategies and developments: Zealand Pharma A/S
FIG 10 Recent strategies and developments: Arkray, Inc.